Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Interstial pneumopathy after low dose bleomycin therapy]

F Frey, C Marone, A Zimmermann

    Schweizerische Medizinische Wochenschrift
    |October 8, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Conserving large populations of lions - the argument for fences has holes.

    Ecology letters·2013
    Same author

    Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.

    European journal of cancer (Oxford, England : 1990)·2013
    Same author

    Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV.

    Physical review letters·2013
    Same author

    Ambiguous genitalia and hypertension in a patient with congenital adrenal hyperplasia.

    Internal medicine journal·2013
    Same author

    Charge separation relative to the reaction plane in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV.

    Physical review letters·2013
    Same author

    Pseudorapidity density of charged particles in p+Pb collisions at √(s(NN))=5.02 TeV.

    Physical review letters·2013
    Same journal

    Respiratory function test in the case of temporary phrenic nerve contusion, associated with pneumoperitoneum; About the diagnostic value of laparoscopy.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Treatment of pulmonary tuberculosis and pleurisy by means of temporary paralysis of the diaphragm, supported by the pneumoperitoneum.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Boeck's disease as a tuberculous syndrome.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Enteral primary tubercular complexes

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Tuberculous stenoses of the large bronchi.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    About the enzyme action.

    Schweizerische medizinische Wochenschrift·2010
    See all related articles

    A woman developed interstitial pneumopathy after a low dose of bleomycin for an unclassifiable neoplasm. Previous chest irradiation may have increased her risk for this severe bleomycin side effect.

    Area of Science:

    • Oncology
    • Pulmonology
    • Toxicology

    Background:

    • Bleomycin is a chemotherapy agent used to treat various cancers.
    • Interstitial pneumopathy is a known, potentially fatal side effect of bleomycin therapy.
    • Previous thoracic radiation therapy can increase the risk of pulmonary toxicity from chemotherapy.

    Observation:

    • A 52-year-old woman received a total dose of 97 mg/m2 bleomycin for an unclassifiable neoplasm of the liver, spleen, and bone marrow.
    • The patient had a history of round cell sarcoma treated with thoracic irradiation 22 years prior to bleomycin treatment.

    Findings:

    • The patient developed interstitial pneumopathy following bleomycin treatment.
    • The low cumulative bleomycin dose suggests that prior thoracic irradiation was a significant contributing factor to the pulmonary toxicity.

    Related Experiment Videos

  • This case highlights the potential for severe bleomycin-induced lung injury even at low doses in patients with a history of chest radiation.

    • Implications:

    • Clinicians should carefully consider cumulative bleomycin dosage and prior thoracic radiation when assessing pulmonary toxicity risk.
    • Enhanced surveillance for interstitial pneumopathy may be warranted in patients with a history of chest irradiation undergoing bleomycin therapy.
    • This case underscores the importance of a thorough patient history in predicting and managing adverse drug reactions in oncology.